Compared with the cases with CARM1 change, Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) cases without altered CARM1 show better prognosis in PFS (P = 0.0239) and DFS (P = 2.892e-5), but not OS (P = 0.883) and DSS (P = 0.870). This evidence concerns the gene CARM1 and cervical squamous cell carcinoma.